ELVN
Enliven Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Enliven Therapeutics (ELVN) Stock: Buy, Sell, or Hold?
$51.79
+0.59 (+1.15%)
▲
5d:
+9.61%
30d:
+31.15%
90d:
-10.8%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 11, 2026
0d
Protect ELVN Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (38%)
Quality Score
33/100
Position
EXTENDED
30-Day Fair Range
$39.62 – $47.31
Position: EXTENDED
Forward P/E & Valuation
-25.7x
Next 12M consensus est.
Wall Street Target
$74.33
+45.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$43.23 / $52.23
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ELVN shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ELVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ELVN is currently trading at $51.79, which is considered extended relative to its 30-day fair value range of $39.62 to $47.31.
Technical Outlook: Technically, ELVN is in a downtrend. The price is approaching resistance at $52.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELVN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $74.33 (+45.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELVN is in a downtrend. The price is approaching resistance at $52.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELVN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $74.33 (+45.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$39.62 -
$47.31
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
37.5%
Trading Range & Key Levels
30-Day Trading Range
$39.62 -
$47.31
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.09
(6.0%)
Support Level
$43.23
Resistance Level
$52.23
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding ELVN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range (+9.5% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.2% below Wall St target ($74.33)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-25.72
Wall Street Target
$74.33
(+45.2%)
Share ELVN Analysis
Share this live ELVN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ELVN)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits users express bullish sentiment towards $ELVN after a strong end to the week.
Key Retail Themes:
Strength in stock prices
Positive investor sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 3:09 PM ET
Data refreshes hourly during market hours. Next update: 4:09 PM
Data refreshes hourly during market hours. Next update: 4:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 52 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 38 SELL |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
Advanced ELVN Option Strategies
Professional options setups generated by AI based on today's ELVN price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ELVN Research Pages
